Join EveryCat’s “Let’s Get CATletic” Virtual 5k Fundraiser Run May 1-31, 2022! Get registered now,  individually or as a team,  and start fundraising early! Help support feline health studies. For more information, click HERE

Grants

W14-036: Developing new drugs for the treatment of feline Tritrichomonas foetus infection

Tritrichomonas foetus is an important and common parasitic infection of domestic cats. The parasite can cause severe inflammation of the colon and subsequent diarrhea, resulting in discomfort for the infected cat and frustration for the owner. Eradication of the infection is challenging for veterinarians and breeders alike. Different drugs have been tried for the treatment of T. foetus infection, but with limited success. The current standard of care is ronidazole, but treatment failures are common and drug resistance has been demonstrated in laboratory tests. The researchers have generated a new collection of over 1,000 promising antimicrobial drug candidates similar to ronidazole. Many of the candidates have enhanced activities against other parasites commonly treated with ronidazole and similar drugs. The objective of this proposal is to test their entire drug collection for superior activity against T. foetus and to begin assessing the best compounds for activity in a novel rodent model of intestinal T. foetus infection. Data from these screening studies will be critical for developing the best drug candidates as novel veterinary medicines for the improved treatment of drug-­‐resistant feline T. foetus infection.

Grant ID: W14-036

Status: Active

Year Funded: 2014

Amount awarded: $15,000

Investigator: Lars Eckmann, Yukiko Miyamoto; University of California-­‐San Diego